Literature DB >> 26545131

[The role of supply-side characteristics of services in AIDS mortality in Mexico].

Sergio Bautista-Arredondo1, Edson Serván-Mori1, Omar Silverman-Retana1, David Contreras-Loya1, Martín Romero-Martínez1, Carlos Magis-Rodríguez2, Patricia Uribe-Zúñiga2, Rafael Lozano3.   

Abstract

OBJECTIVE: To document the association between supply-side determinants and AIDS mortality in Mexico between 2008 and 2013.
MATERIALS AND METHODS: We analyzed the SALVAR database (system for antiretroviral management, logistics and surveillance) as well as data collected through a nationally representative survey in health facilities. We used multivariate logit regression models to estimate the association between supply-side characteristics, namely management, training and experience of health care providers, and AIDS mortality, distinguishing early and non-early mortality and controlling for clinical indicators of the patients.
RESULTS: Clinic status of the patients (initial CD4 and viral load) explain 44.4% of the variability of early mortality across clinics and 13.8% of the variability in non-early mortality. Supply-side characteristics increase explanatory power of the models by 16% in the case of early mortality, and 96% in the case of non-early mortality.
CONCLUSIONS: Aspects of management and implementation of services contribute significantly to explain AIDS mortality in Mexico. Improving these aspects of the national program, can similarly improve its results.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26545131

Source DB:  PubMed          Journal:  Salud Publica Mex        ISSN: 0036-3634


  1 in total

1.  Explaining the heterogeneity in average costs per HIV/AIDS patient in Nigeria: The role of supply-side and service delivery characteristics.

Authors:  Sergio Bautista-Arredondo; M Arantxa Colchero; Ogbonna O Amanze; Gina La Hera-Fuentes; Omar Silverman-Retana; David Contreras-Loya; Gregory A Ashefor; Kayode M Ogungbemi
Journal:  PLoS One       Date:  2018-05-02       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.